Alpha DNA Investment Management’s Expeditors International EXPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,921
Closed -$545K 71
2024
Q4
$545K Sell
4,921
-1,438
-23% -$172K 0.21% 98
2024
Q3
$836K Buy
+6,359
New +$779K 0.31% 69
2021
Q2
Sell
-354
Closed -$37K 281
2021
Q1
$37K Hold
354
0.04% 210
2020
Q4
$33K Buy
+354
New +$32.2K 0.04% 213

Other funds holding EXPD

Alpha DNA Investment Management's EXPD Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Expeditors International (EXPD) in Q1 2025, closing a stake of 4,921 shares — an estimated $545K sold.

Alpha DNA Investment Management first reported a position in EXPD in Q4 2020 and held it in 4 quarters. The position peaked at $836K in Q3 2024. 839 funds tracked by Wall St. Rank hold EXPD as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Expeditors International position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4,921 Expeditors International shares in Q1 2025, an estimated $545K.
  • Alpha DNA Investment Management first reported a position in Expeditors International in Q4 2020 and held it in 4 quarters.
  • Alpha DNA Investment Management's Expeditors International position peaked at $836K in Q3 2024.
  • 839 funds tracked by Wall St. Rank held Expeditors International as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.